Liver Diseases  >>  sunitinib  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
sunitinib / Generic mfg.
NCT00699374 / 2007-006637-14: Study Of Sunitinib Malate Versus Sorafenib In Patients With Inoperable Liver Cancer

Checkmark P3 data
Jun 2011 - Jun 2011: P3 data
Checkmark Data
Jun 2011 - Jun 2011: Data
Terminated
3
1075
Japan, US, Canada, Europe, RoW
sunitinib malate, Sutent®, sorafenib, Nexavar®
Pfizer
Carcinoma, Hepatocellular
12/11
12/11

Download Options